A-TRAIN
Unknown
506 enrolled
TITANIUM
Unknown
120 enrolled
LUXA
Unknown
300 enrolled
DORA
Unknown
100 enrolled
SUCCEEDER
Unknown
154 enrolled
From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
Unknown
80 enrolled
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Unknown
200 enrolled
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Unknown
45 enrolled
IACOL
Unknown
1,000 enrolled
Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients
Unknown
200 enrolled
STOPOVCA
Unknown
10,000 enrolled
SUROVA
Unknown
5,000 enrolled
Follow-up in Gynecological Cancer Survivors
Unknown
1,100 enrolled
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
Unknown
40 enrolled
IMMUNOPARP
Unknown
50 enrolled
Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Evolvement
Unknown
500 enrolled
Construction of Gynecological Tumor Organoids
Unknown
200 enrolled
EPIcol
Unknown
180 enrolled
Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools
Unknown
2,905 enrolled
In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?
Unknown
100 enrolled
HPV Viral Load in Predicting the Prognosis of LSIL
Unknown
1,000 enrolled
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
Unknown
4,000 enrolled
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
Unknown
1,000 enrolled
Validation of the Genetic Signature 354849 as a Prognostic Method
Unknown
189 enrolled
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer
Unknown
465 enrolled
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy
Unknown
95 enrolled
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Unknown
1,000 enrolled
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
Unknown
216 enrolled
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-II
Unknown
2,935 enrolled
HPV-Vac-S
Unknown
5,500 enrolled
Ketohexokinase Isoforms in Endometrial Cancer.
Unknown
220 enrolled
Factors Affecting the Prognosis of Early Ovarian Cancer
Unknown
300 enrolled
Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
Unknown
50 enrolled
The Culture of Ovarian Cancer Organoids and Drug Screening
Unknown
30 enrolled
The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening
Unknown
30 enrolled
MOLLY
Unknown
25 enrolled
Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening
Unknown
84 enrolled
Vulvar Cancer Individualized Scoring System (VCISS)
Unknown
1,000 enrolled
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Unknown
20 enrolled
A Retrospective Study on Multiple Classifier Endometrial Cancer
Unknown
80 enrolled
Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer
Unknown
20 enrolled
OutCoME
Unknown
75 enrolled
PAPILLO-VIH
Unknown
200 enrolled
Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy
Unknown
400 enrolled
Malignant Pediatric Pelvic Tumors: A Retrospective Study
Unknown
90 enrolled
ctDNA-endo
Unknown
130 enrolled
Gynecolunity
Unknown
55 enrolled
Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy
Unknown
3,000 enrolled
RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
Unknown
12 enrolled
LHPCV
Unknown
600 enrolled